DrugPatentWatch Database Preview

Details for Patent: 6,582,727

« Back to Dashboard

Which drugs does patent 6,582,727 protect, and when does it expire?

Patent 6,582,727 protects RAYALDEE and is included in one NDA.

This patent has twenty-nine patent family members in twenty countries.

Summary for Patent: 6,582,727

Title:	Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
Abstract:	Disclosed herein are composition comprising a modified starch and a carrageenan, especially iota-carrageenan, where the compositions are suitable for use in manufacturing soft capsules.
Inventor(s):	Tanner; Keith Edward (Safety Harbor, FL), Getz; John J. (Delray Beach, FL), Burnett; Stephen W. (Clearwater, FL), Youngblood; Elizabeth (Valrico, FL), Draper; Peter Robert (LaSalle, CA)
Assignee:	R. P. Scherer Technologies, Inc. (Paradise Valley, NV)
Application Number:	10/008,694
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 6,582,727
Patent Claim Types: see list of patent claims	Composition; Dosage form;

Drugs Protected by US Patent 6,582,727

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Opko Ireland Global	RAYALDEE	calcifediol	CAPSULE, EXTENDED RELEASE;ORAL	208010-001	Jun 17, 2016		RX	Yes	Yes			Y

International Family Members for US Patent 6,582,727

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	345113
Australia	6071500
Australia	735699
Brazil	0011489
Canada	2375652